Microbial Colonization Clinical Trial
Official title:
The Effects of Omega-3 Polyunsaturated Fatty Acids on the Infant Microbiome and Immunity
Prenatal supplementation with fish oil, rich in omega-3 polyunsaturated fatty acids, is widely recommended in Canada. The aim of this observational, prospective cohort study is to determine the effects of maternal fish oil supplements on the development of their infants' gut microbiota and immunity.
During infancy, the gastrointestinal tract is colonized with microbiota, a community of
microorganisms, which play a significant role in the development, regulation, and maintenance
of immune functions. Fish oil, rich in n-3 polyunsaturated fatty acids (PUFA), are thought to
be anti-inflammatory and consequently may increase susceptibility to infection by hindering
their body's ability to produce an adequate inflammatory response in defense against
infectious disease. Currently, women in Canada are supplementing their diets with n-3 PUFA
during gestation and lactation despite their being conflicting clinical evidence regarding
the beneficial effects on infant development. It is currently unknown how maternal fish oil
supplementation impacts the offspring's gut microbiota and immune functions. Considering that
diet influences microbiota and maternal microbiota is passed from mother to infant, the
investigators hypothesize that maternal fish oil supplementation will affect the
participants' infant gut microbiota and immunity.
This study will evaluate the effects of postnatal n-3 PUFA supplementation in breast milk on
the fecal microbiome in infants over a six-month period. The investigators will analyze the
fecal microbiome of infants born to mothers in the fish oil and non-fish oil groups via next
generation sequencing. As short-chain fatty acids (SCFA) are produced by gut bacteria and
affect immunity, the investigators will analyze SCFA in stool through gas chromatography.
Markers of inflammation like fecal calprotectin and sIgA in stool samples will also be
identified.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05414994 -
Assessment of the Ocular Microbiome in Health and Disease
|
||
| Completed |
NCT04769882 -
Er:YAG Laser Effects on Microbial Population in Conservative Dentistry
|
N/A | |
| Completed |
NCT04766528 -
Effect of Diet on the Microbiota / Endoccanabinoidome Axis in Response to Physical Activity
|
N/A | |
| Completed |
NCT03720314 -
Microbiota Profiling in IBS
|
||
| Completed |
NCT04122612 -
Shaping Microbiome in the First 1,000 Days of Life
|
||
| Not yet recruiting |
NCT05405634 -
Microbiota in Chronic Anal Fissure and Its Association With Prognosis
|
||
| Not yet recruiting |
NCT04895774 -
Ex Vivo Study of the Mechanism of Action of Active Ingredients on the Intestinal Microbiota
|
||
| Recruiting |
NCT05992688 -
The Sweet Kids Study (Stevia on Weight and Energy Effect Over Time)
|
N/A | |
| Recruiting |
NCT05502380 -
Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected Orthopedic Surgery
|
Phase 3 | |
| Completed |
NCT05175833 -
Oral Probiotics and Secondary Bacterial Pneumonia in Severe COVID-19
|
Phase 2 | |
| Recruiting |
NCT04836910 -
Microbiome and Polycystic Ovaries
|
||
| Recruiting |
NCT05603650 -
Effects of Mouthrinses on the Microbiome of the Oral Cavity and GI Tract
|
N/A | |
| Completed |
NCT05575050 -
Impact of Teeth Brushing in Ventilated COVID-19 Patients.
|
N/A | |
| Completed |
NCT04991818 -
MSC - OneBiome UX Pilot Study
|
N/A | |
| Completed |
NCT04374955 -
The Effect of Probiotic Added to Maternal Diet on Infantile Colic and Intestinal Microbiota Content
|
N/A | |
| Recruiting |
NCT04140747 -
Transfer of Strictly Anaerobe Microbes From Mother to Child
|
||
| Recruiting |
NCT04111471 -
The Use of A Prebiotic to Promote a Healthy Gut Microbiome in Pediatric Stem Cell Transplant Recipients
|
N/A | |
| Suspended |
NCT03220282 -
The Milk, Growth and Microbiota Study
|
N/A | |
| Completed |
NCT03422562 -
Probiotics and Intestinal Microbiome in Preterm Infants
|
Phase 3 | |
| Recruiting |
NCT05695196 -
Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant
|
Phase 1 |